The role of temozolomide in the management of patients with newly diagnosed anaplastic astrocytoma: a comparison of survival in the era prior to and following the availability of temozolomide

Eitemau Tebyg

• NT-01 UTILITY OF TEMOZOLOMIDE IN THE MANAGEMENT OF ANAPLASTIC ASTROCYTOMA: A COMPARISON OF SURVIVAL IN THE ERA PRIOR TO AND FOLLOWING TEMOZOLOMIDE
  gan: Abuali, Inas, et al.
  Cyhoeddwyd: (2014)
• Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era
  gan: Paravati, Anthony J., et al.
  Cyhoeddwyd: (2010)
• Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide on Research Studies in the United States
  gan: Grossman, Stuart A., et al.
  Cyhoeddwyd: (2010)
• Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma
  gan: Brandes, Alba A., et al.
  Cyhoeddwyd: (2006)
• AT-27 CHALLENGES OF RETROSPECTIVELY DETERMINING THE EQUIVALENCE OF PCV VERSUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED 1p/19q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMAS
  gan: Jain, Rohit, et al.
  Cyhoeddwyd: (2014)